Migraine without aura
Conditions
Interventions
Experimental group:Contralateral acupuncture
Control group1:ipsilateral acupuncture
Control group 2:Sham contralateral acupuncture
Sponsors
Yunnan University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Unilateral migraine, women, age is between 18-60 years old (the starting age is less than 50 years old); 2. Meet the ICHD-3 diagnostic criteria for MwoA; 3. In the past 3 months, the number of monthly migraine attacks is greater than or equal to 2 times, and the number of migraine days is less than 15 days per month; 4. The severity of migraine attacks in the past 4 weeks (baseline period) is moderate to severe (average VAS score 4-9); 5. Have a history of migraine for more than one year; 6. Have not received acupuncture treatment within 1 month; 7. Volunteer to participate and sign the informed consent; 8. No other trials were taken within three months.
Exclusion criteria
Exclusion criteria: 1. Patients with bilateral or alternating unilateral migraine; 2. People with a history of head trauma, other primary headaches and headaches of unknown diagnosis, or cervicogenic headache; 3. Combined with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic systems and other organic diseases; 4. Combined with severe anxiety, depression, insomnia, and another psychiatric disease or intellectual disabilities who cannot cooperate with the questionnaire, or infection, bleeding disorders, allergies and skin diseases; 5. Pregnancy, lactation, or those who have fertility requirements in the next 6 months. 6. Long-term or current use of analgesic drugs and psychotropic drug dependence. 7. Cannot understand or record the headache diary; 8. Those who have participated in similar research within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Days of migraine attacks; | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of migraine attacks;Intensity of migraine;migraine duration;the dose of intake of acute medication;Migraine Specific Quality of Life Questionnaire, MSQ;Migraine Disability Assessment, MIDAS;Headache impact scale;pittsburgh sleep quality index, PSQI; | — |
Countries
China
Contacts
Public ContactGuo Taipin
Yunnan University of Chinese Medicine
Outcome results
None listed